155 related articles for article (PubMed ID: 8528966)
1. Adjuvant therapy for resectable gastric adenocarcinoma: preoperative and postoperative chemotherapy trials.
Leach SD; Lowy AM; Mansfield PF; Ajani JA
J Infus Chemother; 1995; 5(3):104-11. PubMed ID: 8528966
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant and neoadjuvant therapy for gastric cancer.
Kelsen DP
Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of gastric cancer: a review.
Kelsen D
Isr J Med Sci; 1988; 24(9-10):557-61. PubMed ID: 3060446
[TBL] [Abstract][Full Text] [Related]
4. Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States.
Ohtsu A; Sasako M
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S101-4. PubMed ID: 16399444
[TBL] [Abstract][Full Text] [Related]
5. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
Yu W
Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
[TBL] [Abstract][Full Text] [Related]
6. Combined modality therapy of gastric cancer.
Karpeh MS; Kelsen DP
Surg Oncol Clin N Am; 1997 Oct; 6(4):741-7. PubMed ID: 9309091
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer?].
Kretzschmar A; Schlag PM
Zentralbl Chir; 2006 Apr; 131(2):121-5. PubMed ID: 16612778
[TBL] [Abstract][Full Text] [Related]
8. [Neoadjuvant chemotherapy in gastric carcinoma].
D'Ugo D; Persiani R; Pende V; Picciocchi A
Ann Ital Chir; 2001; 72(1):47-53. PubMed ID: 11464495
[TBL] [Abstract][Full Text] [Related]
9. [The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma].
Ausch C; Rosen HR; Schiessel R
Wien Klin Wochenschr; 1996; 108(16):496-504. PubMed ID: 8967093
[TBL] [Abstract][Full Text] [Related]
10. Postoperative chemotherapy for gastric cancer.
Hejna M; Wöhrer S; Schmidinger M; Raderer M
Oncologist; 2006 Feb; 11(2):136-45. PubMed ID: 16476834
[TBL] [Abstract][Full Text] [Related]
11. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601.
Findlay M; Storey D; Gebski V; Hargreaves C; Cullingford G; Boyer M; Trotter J; Archer S; Davidson A; Johnston P; Yuen J; Dhillon H; Della-Fiorentina S; Richardson G; Truskett P; Goldstein D;
ANZ J Surg; 2007 Apr; 77(4):247-52. PubMed ID: 17388828
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
Ajani JA; Winter K; Okawara GS; Donohue JH; Pisters PW; Crane CH; Greskovich JF; Anne PR; Bradley JD; Willett C; Rich TA
J Clin Oncol; 2006 Aug; 24(24):3953-8. PubMed ID: 16921048
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
[TBL] [Abstract][Full Text] [Related]
15. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial.
Lygidakis NJ; Sgourakis G; Aphinives P
Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393
[TBL] [Abstract][Full Text] [Related]
16. The role of irradiation as a component of combined modality treatment for gastric cancer.
Gunderson LL; Burch PA; Donohue JH
J Infus Chemother; 1995; 5(3):117-24. PubMed ID: 8528968
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy options for gastric cancer.
Meyerhardt JA; Fuchs CS
Semin Radiat Oncol; 2002 Apr; 12(2):176-86. PubMed ID: 11979419
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
[TBL] [Abstract][Full Text] [Related]
19. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
Kim S; Lim DH; Lee J; Kang WK; MacDonald JS; Park CH; Park SH; Lee SH; Kim K; Park JO; Kim WS; Jung CW; Park YS; Im YH; Sohn TS; Noh JH; Heo JS; Kim YI; Park CK; Park K
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1279-85. PubMed ID: 16099596
[TBL] [Abstract][Full Text] [Related]
20. Local recurrence following adjuvant chemotherapy without radiotherapy in completely resected stomach and gastroesophageal junction adenocarcinoma.
Bar-Sela G; Tsalic M; Steiner M; Wollner M; Haim N
Anticancer Res; 2009 May; 29(5):1853-6. PubMed ID: 19443416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]